FSSAI pulls up Dr Reddy's, Nestle Health Science over Celevida claims

New Delhi: Food safety regulator FSSAI has issued notices to Dr Reddy's and Nestle Health Science, Flipkart, Amazon and three other entities over allegedly misleading advertising and health claims for Celevida GLP+, a nutrition product marketed on ecommerce platforms. The Food Safety and Standards Authority of India (FSSAI) said the product was advertised as providing high-protein support for preserving lean muscle during GLP-1/GIP therapies, commonly used in weight-loss treatment.

The Food Safety and Standards Authority of India (FSSAI) said the product was advertised as providing high-protein support for preserving lean muscle during GLP-1/GIP therapies, commonly used in weight-loss treatment.

Summarised by Agaah from ET Industry. Agaah aggregates 36 sources and removes duplicate coverage — all news, one place.